BEIGENE, LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 198.49 USD | +1.13% |
|
+3.75% | +10.05% |
Company Valuation: BeiGene, Ltd.
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 10,134 | 23,494 | 27,843 | 22,843 | 18,862 | 21,104 | - | - |
| Change | - | 131.83% | 18.51% | -17.96% | -17.43% | 11.89% | - | - |
| Enterprise Value (EV) 1 | 9,392 | 19,361 | 24,097 | 19,511 | 16,564 | 19,364 | 19,515 | 19,042 |
| Change | - | 106.15% | 24.46% | -19.03% | -15.1% | 16.9% | 0.78% | -2.43% |
| P/E ratio | -10.5x | -13.5x | -17.8x | -11.3x | -21.3x | -32.6x | -198x | 41.3x |
| PBR | 11.2x | 5.57x | 4.03x | 5.17x | 5.32x | 6.33x | 6.36x | 4.93x |
| PEG | - | -0.6x | 0.9x | -0.4x | 0.4x | 1.2x | 2.4x | -0x |
| Capitalization / Revenue | 23.7x | 76.1x | 23.7x | 16.1x | 7.67x | 5.84x | 4.65x | 3.76x |
| EV / Revenue | 21.9x | 62.7x | 20.5x | 13.8x | 6.74x | 5.36x | 4.3x | 3.39x |
| EV / EBITDA | -9.98x | -11.9x | -17.3x | -11.3x | -14.8x | -32.9x | -209x | 43.2x |
| EV / EBIT | -9.78x | -11.7x | -16.7x | -10.9x | -13.7x | -27.3x | -83.8x | 67x |
| EV / FCF | -11.2x | -13.8x | -15.4x | -10.7x | -9.63x | -31.8x | -58x | 72.1x |
| FCF Yield | -8.94% | -7.24% | -6.48% | -9.34% | -10.4% | -3.15% | -1.72% | 1.39% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -15.8 | -19.13 | -15.23 | -19.43 | -8.45 | -6.09 | -1.001 | 4.804 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 428.2 | 308.9 | 1,176 | 1,416 | 2,459 | 3,614 | 4,535 | 5,611 |
| EBITDA 1 | -941.3 | -1,626 | -1,392 | -1,723 | -1,120 | -587.8 | -93.25 | 440.4 |
| EBIT 1 | -959.9 | -1,658 | -1,439 | -1,790 | -1,208 | -709.6 | -232.9 | 284.3 |
| Net income 1 | -948.6 | -1,597 | -1,413 | -2,004 | -881.7 | -683.1 | -168.3 | 370.6 |
| Net Debt 1 | -742 | -4,132 | -3,746 | -3,332 | -2,297 | -1,740 | -1,588 | -2,062 |
| Reference price 2 | 165.76 | 258.39 | 270.93 | 219.94 | 180.36 | 198.49 | 198.49 | 198.49 |
| Nbr of stocks (in thousands) | 61,136 | 90,924 | 1,02,770 | 1,03,859 | 1,04,578 | 1,06,321 | - | - |
| Announcement Date | 02/03/20 | 25/02/21 | 25/02/22 | 27/02/23 | 26/02/24 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E ratio | EV / Sales | EV / EBITDA | Yield (Y) | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -32.6x | 5.36x | -32.94x | -.--% | 21.1B | ||
| -244.92x | 10.73x | 141.27x | -.--% | 125B | ||
| 30.95x | 8.15x | 19.85x | -.--% | 124B | ||
| -529.73x | 14.58x | -177.05x | -.--% | 32.35B | ||
| -50.33x | 5.09x | -14.66x | -.--% | 29.34B | ||
| 21.82x | 4.31x | 14.13x | -.--% | 16.98B | ||
| 12.13x | 2.65x | 7.51x | +2.42% | 16.01B | ||
| -25.89x | - | - | -.--% | 14.35B | ||
| -14.37x | 37.48x | -17.48x | -.--% | 12.83B | ||
| Average | -92.55x | 11.04x | -7.42x | +0.27% | 43.64B | |
| Weighted average by Cap. | -117.44x | 9.75x | 35.55x | +0.10% |
Year-on-year evolution of the PER
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- BGNE Stock
- Valuation BeiGene, Ltd.
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition